Commure Stock
Commure provides an FHIR-compliant development platform for health systems, vendors and startups to build healthcare applications and software.
Sign up for SecondMarket™ to view the market and buy or sell Commure Stock
Buy + SellCommure Funding
Sign up to gain insights into Commure funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Oct 23, 2023 | 0.00 | |||
Sep 22, 2023 | Series D | 38.72M | ||
Dec 31, 2021 | Series D | 3.75M | ||
Sep 13, 2021 | Series D | 150.00M | ||
Sep 01, 2021 | Series C | 141.44M | ||
Sep 01, 2021 | Series C | 7.56M | ||
Nov 19, 2020 | Series C | 210.25M | ||
Apr 12, 2019 | Series B | 27.00M | ||
Jun 05, 2018 | Series B | 24.84M | ||
Dec 27, 2017 | Series A | 10.00M | ||
Sep 19, 2017 | Series Seed | 2.00M |
See Commure Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Commure Stock Valuation + Share Prices
View real-time Tape D™ data on Commure stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedCommure Management Team
Director
Teresa Carlson
Director
Michael Schlosser
Chief Financial Officer
Chris Kuhns
Director
Qasar Younis
Chief Health Officer
Saurabha Bhatnager
CEO, Director
Tanay Tandon
Director
Deepika Bodapati
Chief Growth Officer
Manisha Shetty Gulati
Chief Product and Engineering Officer
Abhijit Mitra
Director
Quentin Clark
Co-Founder, Executive Chair, Director
Hemant Taneja
Commure Major Investors
Human Capital
Greenoaks Capital Management